INS and chronic kidney disease: Alternatively, compensatory mechanisms that have been suggested to enhance tolerance to elevated serum K+ concentrations in advanced CKD (e.g., altered gastrointestinal secretion of K+ or increased insulin-mediated K+ reabsorption)30 may have negated the harmful effects of hyperkalemia in patients with CKD stage 4.